What Investors Are Watching For In Regulus Therapeutics' Next Data Release
January 30, 2015 at 14:32 PM EST
Biotech companies that treat Hepatitis C were on fire in 2014. The leader of the pack, Gilead Sciences, Inc. (NASDAQ: GILD), had the ...
